Renaissance Capital logo

Recursion Pharmaceuticals Priced, Nasdaq: RXRX

Phase 2-ready biotech using AI to develop therapies for rare diseases.

Industry: Health Care

First Day Return: +73.9%

Industry: Health Care

We are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world’s largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. The combination of wet-lab biology and in silico tools in our closed-loop system differentiates us from others within the industry. Similarly, our balanced team of life scientists and computational and technical experts creates an environment where empirical data, statistical rigor, and creative thinking are brought to bear on our decisions. Every program at Recursion is a product of our Recursion OS. While we are advancing 37 programs, we highlight ten 'Notable Programs' that are key, near-term value drivers given their individual market opportunities and the validation they provide for each generation of the Recursion OS.
more less
IPO Data
IPO File Date 03/22/2021
Offer Price $18.00
Price Range $16.00 - $18.00
Offer Shares (mm) 24.2
Deal Size ($mm) $436
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 04/15/2021
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $436
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Salt Lake City, UT, United States
Founded 2013
Employees at IPO 218
Website www.recursionpharma.com

Recursion Pharmaceuticals (RXRX) Performance